Opioid Abuse and Addiction

last authored: April 2012, David LaPierre
last reviewed:

 

 

Introduction

Pain and addiction can co-exist. Addictions have a prevalence of 3-15%, with varying rates of drug, gender, etc.

Predisposition does not mean predestination.

Abuse of prescription medications has skyrocketed. The most common medications include:

There is a continuum of pain and addiction. Some patients sit in both camps.

 

When the drug is both the problem and solution, care can be made quite challenging.

Most patients don't need strict boundary setting, as they have their own internal set.

 

It is important to have a high index of suspicion for drug-seeking behaviour.

 

A single question -- "How many times in the past year have you used an illegal drug or used a prescripton medication for nonmedical reasons?" -- can effectively rule out drug abuse in a high prevalence population (Smith et al, 2010).

 

Death by overdose is now the 2nd most common cause of accidental death, after motor vehicle collisions, in Ontario (Sharon Baker, personal communication).

 

Addiction treatment is poorly funded.

Harm reduction strategies save lives. As drugs of abuse change, the methods of harm reduction need to change as well.

 

A huge level of this is iatrogenic.

 

Heroin was named for its heroic ability to suppress cough, patented by Bayer in 1898.

The Hague convention made it illegal in 1912, and a huge need for treatment arose. Morphine maitenance clinics were started, with the intent of controlling the amount and timing of opioid use.

 

 

Canada is the leading country in the world for opioid prescrptions (ref).

 

 

 

Universal Precautions in Pain Medicine

It is prudent to consider addiction in all patients.

Thoroughly inquire into drug and alcohol history in all patients.

triage for risk

When prescribing opioids

return to top

 

 

 

Dependence and Addiction

We need to use precise definitions around abuse, dependency, and addiction.

Addiction is a primary disorder, with continued use despite harm. An addicted enviroment's environment contracts with addiction.

Physical dependence is a state of adaptation...

Tolerance is a state of adaptation in which exposure to a drug induces changes that result in a decreased effect over time. Tolerance occurs as the body's signals state that

 

Pseudoaddiction is an iatrogenic misinterpretation of maladaptive behaviour resulting from inadequate pain control. This behaviour stops when adequate pain relief is provided.

 

Boundaries:

 

Addiction is a biopsychosocial issue.

One needs:

 

People prefer oral, prescribed medications because:

 

 

return to top

 

 

 

Diversion

Most opioids on the street started as legal prescriptions that are then sold.

Patients divert for money, to support their own habit, or to fund other criminal activity.

return to top

 

 

 

Warning Signs

Be aware of the alarms and be forthright with addressing these.

 

Other warning signs include:

 

Signs that are suggestive of addiction

 

 

Other considerations.

Comorbid psychopathology

Underlying primary addiction

 

Warning signs of drug abuse include:

return to top

 

 

 

 

Discussing Addictions

It may be appropriate to discuss their addiction with the patient. You may ask about:

return to top

 

 

 

Prescribing Strategies

Universal precautions are important; this ensures patients, prescribers, and society are protected, particularly in regards to the inability to identify the 'at risk patient'

Do a physical exam for track marks

Ask about it, and do a history

Assess risk and use objective measures; the Partners against Pain

Trust instincts and prescribe rationally.

Use tight boundaries when needed.

Urine drug testing.

 

 

Get patients to bring in their medications when they come in for an appointment.

Ask the patients "What are you doing for your pain?", as looking to medications only is not ideal. Ensure they are trying to exercise appropriately, not damaging themselves further, caring for themselves, etc.

 

You need to provide a stable anchor for these patients.

If you people are running out; give them a higher dose but many less meds. If this does not work, bring in addictions medicine, but keep them as your patient.

Do not discharge patient if at all possible; they will now be free to wreak havoc in walk-in clinics/emergency departments.

If you set the box too tight, everyone will step out of bounds.

 

Set limits carefully from the outset. It is easier to loosen limits, rather than tighten them.

 

Treatment Agreement

Contract with patient that they do not change the dose on their own.

 

One strategy is to call the patient and say 'I need you here today. Bring your pills.' and then count the medications to ensure they are not diverting.

 

 

If tolerance is an issue, one can:

return to top

 

 

 

Urine Drug Screening

Urine drug screening (UDS) is cheap, effective, and well-tolerated. It is helpful to develop a relationship with the testing lab to assist in interpretation.

not helpful for complaince testing

return to top

 

 

 

Withdrawal

There are different levels

Supporting psychosocial factors, eg by providing daycare, can increase successful completion.

Further options include:

The stages of change model is important

Precontemplation, contemplation, and preparation: strengthen the mo

Harm reduction

Prevention strategies build:

 

Gastrointestinal

  • nausea
  • vomiting
  • diarrhea

Cognitive

  • anxiety
  • dysphoria
  • sleep disorder

Muscle and joint pain

 

Autonomic hyperativity:

  • rhinorrhea, lacrimation
  • hypertension, pallor
  • diaphoresis, tachycardia
 

 

 

Medications include:

Bupenorphine taper

Overdose-related death is

 

Naltrexone can be used for maintenance, but it commonly causes dysphoria

return to top

 

 

 

Methadone

"According to guidelines issued by the World Health Organization (WHO), best practice in the 'psychosocially-assisted pharmacological treatment' of opioid dependence consists of methadone maintenance treatment, combined with one or more of a broad range of ancillary support services, such as counselling or contingency management.7 Despite methadone's proven effectiveness and affordability, methadone maintenance treatment is still unavailable in many low- and middle-income countries where it is desperately needed.12 Thus, expansion of treatment coverage to include more of the worlds' opioid users should be prioritized" (Wu and Clark, 2013).

 

Methadone has good success rates. It is not suitable for carries until stable, and their urine is clear, for daily dispensing for at least two months. Many patients stay on methadone life long and others will taper off.

 

 

There is ongoing criticism of methadone. There is huge unmet demand

Frequently there is no system srrounding methadone treatment.

 

Methadone was widely used in Germany as a pain mediaction, termed adophine. In 1962 it was started as a treamtent for 'morphinism'. Methadone maintenance treatment (MMT) was started in the 1960's in the 1960's, used for its 'heroin blocking effect'. Within Canada, political recommendation for expansion was made in the 1970s, though the Canadian Medical Association (CMA) came out strongly against the widespread use of methadone.

In many countries, methadone use has consistently expanded, though in Canada, use has declined.

 

Methadone can be used for maintenance of opioid abuse, as well as for detoxification.

17k for QALY (Sees et al, 2000).

 

Structured education for the health care providers is critical.

 

Dosing is important for long term success; doses of 60mg or more appear the most likely to be of benefit. However, the initial dose should be 30mg or less, related to difficult-to-predict differences in metabolism.

 

Every methadone quit effort increase the chances of success.

return to top

 

 

 

Bupenorphine

Lower rates of overdose

Retention is lower as compared to methadone

Preferred over methadone if:

Diacetylmorphine (heroin) lead to very significant outcomes in regards to retention and response (Oviedo-Joekes et al, 2009).

 

Causes death at much higher rates:

 

Resources and References

Medical Mentored Addictions and Pain

Addiction Clinical Consultation Service 18887202227 (call this number as a doc)

familydocs.org/files/UDTmonograph.pdf

cpso.on.ca/Publications/methpain.pdf

doug_gourlay@camh.net

Smith PC, Schmidt SM, Allensworth-Davies D, Saitz R. 2010. A single-question screening test for drug use in primary care. Arch Intern Med. 170(13):1155-1160.

Wu Z, Clark N. 2013. Scaling up opioid dependence treatment in low- and middle-income settings. Bulletin of the World Health Organization. 91:82-82A.

return to top